A number of arthritis drugs belonging to the
Cox-2 family have been associated with significant heart risks.
Our law firm also is representing people injured by Vioxx and Bextra.
The fallout for these drugs began on September
30, 2004 when Merck announced a worldwide withdrawal of Vioxx.
This recall came after numerous clinical studies (dating back
to as early as 2000) reported significant increases in heart
attacks and strokes among patients.
Physicians immediately expressed concern that
the problem was not limited to Vioxx and may be common among
all Cox-2 Inhibitors. Within weeks of the Vioxx recall, Pfizer
announced that Bextra would be accompanied by a warning after
a study indicated elevated heart risks among high-risk patients |